Transforming growth factor beta 1 (TGF-b1) in the pathophysiology of nasal polyp

Objectives: This study aims to use immunohistochemistry to compare histopathological findings and transforming growth factor beta1 (TGF-b1) levels in polyp tissue in cases of nasal polyp with histopathological findings and TGF-b1 levels in the nasal mucosa inpatients with obstructive nasal deformity.Patients and Methods: The study group consisted of 20 patients. The control group consisted to 20 patients scheduled for nasalsurgery due to septum deviation. Edema, mixed infection cell infiltration, eosinophil leukocyte infiltration and squamous metaplasiadevelopment were studied from hematoxylin-eosin stained slides containing polyp and conchal mucosa tissue specimenscollected from the study and control groups. These were then assessed semi-quantitatively. The presence or absence of TGF-b1antibody and positive reaction in the mucosal epithelium, submucosal glands, fibroblasts and inflammatory cells were evaluatedimmunohistochemically.Results: A positive association was determined between eosinophilia and edema on tissue staining with hematoxylin and eosin incases of nasal polyp, while no edema was observed in any cases in the control group. Comparison of the control and study groups onimmunohistochemical (TGF-b1 positive reaction) staining revealed no significant difference between epithelium, gland and fibroblaststaining. Immunohistochemical staining of inflammatory cells was more pronounced in the study group.Conclusion: We conclude that TGF-b1 may play a role together with other mediators, although not alone, in the pathophysiology ofnasal polyp.

___

1. Bateman ND, Fahy C, Woolford TJ. Nasal polyps: still more questions than answers. J Laryngol Otol 2003;117:1-9.

2. Tos M, Mogensen C. Pathogenesis of nasal polyps. Rhinology 1977;15:87-95.

3. Little SC, Early SB, Woodard CR, Shonka DC Jr, Han JK, Borish L, et al. Dual action of TGF-beta1 on nasal-polyp derived fibroblasts. Laryngoscope 2008;118:320-4.

4. Eisma RJ, Allen JS, Lafreniere D, Leonard G, Kreutzer DL. Eosinophil expression of transforming growth factor-beta and its receptors in nasal polyposis: role of the cytokines in this disease process. Am J Otolaryngol 1997;18:405-11.

5. Costa JJ, Matossian K, Resnick MB, Beil WJ, Wong DT, Gordon JR, et al. Human eosinophils can express the cytokines tumor necrosis factor-alpha and macrophage inflammatory protein-1 alpha. J Clin Invest 1993;91:2673-84.

6. Saji F, Nonaka M, Pawankar R. Expression of RANTES by IL-1 beta and TNF-alpha stimulated nasal polyp fibroblasts. Auris Nasus Larynx 2000;27:247-52.

7. Karjalainen J, Joki-Erkkilä VP, Hulkkonen J, Pessi T, Nieminen MM, Aromaa A, et al. The IL1A genotype is associated with nasal polyposis in asthmatic adults. Allergy 2003;58:393-6.

8. Kirtsreesakul V. Update on nasal polyps: etiopathogenesis. J Med Assoc Thai 2005;88:1966-72.

9. Soyöz M, Özçelik N. TGF-b (Transforming Growth Factor-b) ve sinyal iletimi. Turkiye Klinikleri J Med Sci 2007;27:426- 33.

10. Güner İ, Özmen D, Bayındır O. Sitokinler. Turkiye Klinikleri J Med Sci 1997;17:65-74.

11. Go K, Ishino T, Nakashimo Y, Miyahara N, Ookubo T, Takeno S, et al. Analysis of syndecan-1 and TGFbeta expression in the nasal mucosa and nasal polyps. Auris Nasus Larynx 2010;37:427-35.

12. Staikūniene J, Vaitkus S, Japertiene LM, Ryskiene S. Association of chronic rhinosinusitis with nasal polyps and asthma: clinical and radiological features, allergy and inflammation markers. Medicina (Kaunas) 2008;44:257-65.

13. Behnecke A, Mayr S, Schick B, Iro H, Raithel M. Evaluation of ECP release from intact tissue biopsies from patients with nasal polyps. Inflamm Res 2008;57 Suppl 1:S65-6.

14. Min YG, Kim YJ, Yun YS. Distribution of eosinophil granule proteins in nasal mucosa of atopic patients with nasal polyposis. ORL J Otorhinolaryngol Relat Spec 1996;58:82-6.

15. Soler ZM, Sauer DA, Mace J, Smith TL. Relationship between clinical measures and histopathologic findings in chronic rhinosinusitis. Otolaryngol Head Neck Surg 2009;141:454-61.

16. Mullol J, Roca-Ferrer J, Alobid I, Pujols L, Valero A, Xaubet A, et al. Effect of desloratadine on epithelial cell granulocyte-macrophage colony-stimulating factor secretion and eosinophil survival. Clin Exp Allergy 2006;36:52-8.

17. Min YG, Lee KS. The role of cytokines in rhinosinusitis. J Korean Med Sci 2000;15:255-9.

18. Busaba NY, Sin HJ, Salman SD. Impact of gender on clinical presentation of chronic rhinosinusitis with and without polyposis. J Laryngol Otol 2008;122:1180-4.

19. Woodworth BA, Joseph K, Kaplan AP, Schlosser RJ. Alterations in eotaxin, monocyte chemoattractant protein-4, interleukin-5, and interleukin-13 after systemic steroid treatment for nasal polyps. Otolaryngol Head Neck Surg 2004;131:585-9.

20. Watelet JB, Claeys C, Perez-Novo C, Gevaert P, Van Cauwenberge P, Bachert C. Transforming growth factor beta1 in nasal remodeling: differences between chronic rhinosinusitis and nasal polyposis. Am J Rhinol 2004;18:267-72.

21. Coste A, Lefaucheur JP, Wang QP, Lesprit E, Poron F, Peynegre R, et al. Expression of the transforming growth factor beta isoforms in inflammatory cells of nasal polyps. Arch Otolaryngol Head Neck Surg 1998;124:1361-6.

22. Bachert C, Gevaert P, Holtappels G, Cuvelier C, van Cauwenberge P. Nasal polyposis: from cytokines to growth. Am J Rhinol 2000;14:279-90.

23. Ohno I, Lea RG, Flanders KC, Clark DA, Banwatt D, Dolovich J, et al. Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta 1). J Clin Invest 1992;89:1662-8.

24. Otto BA, Wenzel SE. The role of cytokines in chronic rhinosinusitis with nasal polyps. Curr Opin Otolaryngol Head Neck Surg 2008;16:270-4.

25. Sime PJ, Marr RA, Gauldie D, Xing Z, Hewlett BR, Graham FL, et al. Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta1 and myofibroblasts. Am J Pathol 1998;153:825-32.